Breast Cancer Trial of RPR109881 Versus Capecitabine in Male or Female Patients With Advanced Breast Cancer

Clinical trial NCT00081796 · COMPLETED

Trial details

NCT number: NCT00081796
Sponsor: Sanofi
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Breast Cancer Metastases

Start date: 2004-04-01
Primary completion: 2006-09-01
Enrollment: 438

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.